The US Department of Health and Human Services on Friday announced approximately $2.27 billion in Ryan White HIV/AIDS Program grants were awarded to cities, counties, states, and local community-based organizations in fiscal year (FY) 2019.
This funding, through the Health Resources and Services Administration (HRSA), supports a comprehensive system of HIV primary medical care, medication, and essential support services to more than half a million people with HIV in the USA.
“The Ryan White HIV/AIDS Program has played a major role in the in the improved outcomes we see for Americans with HIV,” said HHS Secretary Alex Azar, explaining: “Thanks to expanded access to treatment and medical advances, HIV/AIDS has gone from being a likely death sentence to a condition that allows a nearly normal lifespan if properly treated. Ryan White HIV/AIDS Program clients, despite often very challenging circumstances, have a viral suppression rate that far exceeds the national average.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze